- Home
- WINT vs EZGO Comparison
WINT vs EZGO Comparison
Compare WINT & EZGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- EZGO
- Stock Information
- Founded
- WINT 1992
- EZGO 2014
- Country
- WINT United States
- EZGO China
- Employees
- WINT N/A
- EZGO N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- EZGO Motor Vehicles
- Sector
- WINT Health Care
- EZGO Consumer Discretionary
- Exchange
- WINT Nasdaq
- EZGO Nasdaq
- Market Cap
- WINT 2.2M
- EZGO 2.0M
- IPO Year
- WINT 1995
- EZGO 2021
- Fundamental
- Price
- WINT $0.49
- EZGO $0.33
- Analyst Decision
- WINT Hold
- EZGO
- Analyst Count
- WINT 1
- EZGO 0
- Target Price
- WINT $350.00
- EZGO N/A
- AVG Volume (30 Days)
- WINT 7.2M
- EZGO 110.0K
- Earning Date
- WINT 08-18-2025
- EZGO 01-17-2025
- Dividend Yield
- WINT N/A
- EZGO N/A
- EPS Growth
- WINT N/A
- EZGO N/A
- EPS
- WINT N/A
- EZGO N/A
- Revenue
- WINT N/A
- EZGO $21,134,425.00
- Revenue This Year
- WINT N/A
- EZGO N/A
- Revenue Next Year
- WINT N/A
- EZGO N/A
- P/E Ratio
- WINT N/A
- EZGO N/A
- Revenue Growth
- WINT N/A
- EZGO 32.75
- 52 Week Low
- WINT $0.36
- EZGO $0.29
- 52 Week High
- WINT $737.44
- EZGO $1.91
- Technical
- Relative Strength Index (RSI)
- WINT 35.91
- EZGO 41.85
- Support Level
- WINT $0.52
- EZGO $0.30
- Resistance Level
- WINT $0.64
- EZGO $0.35
- Average True Range (ATR)
- WINT 0.09
- EZGO 0.02
- MACD
- WINT -0.00
- EZGO -0.00
- Stochastic Oscillator
- WINT 14.12
- EZGO 31.88
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.